UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Nature communications, 2021-09, Vol.12 (1), p.5307-5307, Article 5307

2021

Volltextzugriff (PDF)

King's Health Partners' Prostate Cancer Biobank (KHP PCaBB)

BMC cancer, 2017-11, Vol.17 (1), p.784-784, Article 784

2017

Volltextzugriff (PDF)

Country-wide learning curve of robotic-assisted radical prostatectomy: The Be-RALP database

European urology open science (Online), 2020-07, Vol.19, p.e1984-e1985

2020

Volltextzugriff (PDF)

Longitudinal analysis of urinary- and erectile function after RALP in high- versus low/intermediate-risk prostate cancer in a large prospective database

European urology open science (Online), 2020-07, Vol.19, p.e253-e255

2020

Volltextzugriff (PDF)

A0858 - The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office

European urology, 2024-03, Vol.85, p.S1892-S1892

2024

Volltextzugriff (PDF)

The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office

European urology, 2024-03, Vol.85, p.S1892

2024

Volltextzugriff (PDF)

The androgen receptor depends on ligand‐binding domain dimerization for transcriptional activation

EMBO reports, 2021-12, Vol.22 (12), p.e52764-n/a

2021

Volltextzugriff (PDF)

A0604 - Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

European urology, 2024-03, Vol.85, p.S1517-S1518

2024

Volltextzugriff (PDF)

A0602 - Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

European urology, 2024-03, Vol.85, p.S1514-S1514

2024

Volltextzugriff (PDF)

P047 - Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

European urology, 2024-03, Vol.85, p.S62-S63

2024

Volltextzugriff (PDF)

Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

European urology, 2024-03, Vol.85, p.S62-S63

2024

Volltextzugriff (PDF)

Association between PSMA PET response and oncological outcome following neoadjuvant hormonal therapy in high-risk prostate cancer patients

European urology, 2024-03, Vol.85, p.S78-S79

2024

Volltextzugriff (PDF)

Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

European urology, 2024-03, Vol.85, p.S1514

2024

Volltextzugriff (PDF)

Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

European urology, 2024-03, Vol.85, p.S1517-S1518

2024

Volltextzugriff (PDF)

P059 - Association between PSMA PET response and oncological outcome following neoadjuvant hormonal therapy in high-risk prostate cancer patients

European urology, 2024-03, Vol.85, p.S78-S79

2024

Volltextzugriff (PDF)

Be-RALP study: The effect of adjuvant treatment on quality of life, erectile function and continence

European urology, 2021-06, Vol.79, p.S1647-S1648

2021

Volltextzugriff (PDF)

Listeria monocytogenes tijdens de zwangerschap

Tijdschrift voor geneeskunde, 2020 (5), p.204-208

2020

Volltextzugriff (PDF)

EAU recommendations for the diagnosis and treatment of human papillomavirus infections in men

European urology, 2021-06, Vol.79, p.S449-S450

2021

Volltextzugriff (PDF)

CT texture analysis of ex vivo renal stones predicts ease of fragmentation with shock wave lithotripsy

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e52-e52

2017

Volltextzugriff (PDF)

Longitudinal QoL in patients with high versus low-intermediate risk prostate cancer treated by RALP: A multicentre study

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e1587-e1589

2019

Volltextzugriff (PDF)

594 - Predictive factors of postoperative quality of life, erectile function and continence after robot-assisted radical prostatectomy: A multicentre study

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e788-e789

2019

Volltextzugriff (PDF)

Predictive factors of postoperative quality of life, erectile function and continence after robot-assisted radical prostatectomy: A multicentre study

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e788-e789

2019

Volltextzugriff (PDF)

1181 - Longitudinal QoL in patients with high versus low-intermediate risk prostate cancer treated by RALP: A multicentre study

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e1587-e1589

2019

Volltextzugriff (PDF)

32 - CT texture analysis of ex vivo renal stones predicts ease of fragmentation with shock wave lithotripsy

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e52-e52

2017

Volltextzugriff (PDF)

CT Texture Analysis of Ex Vivo Renal Stones Predicts Ease of Fragmentation with Shockwave Lithotripsy

Journal of endourology, 2017-07, Vol.31 (7), p.694-700

2017

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

King's Health Partners' Prostate Cancer Biobank (KHP PCaBB)

Country-wide learning curve of robotic-assisted radical prostatectomy: The Be-RALP database

Longitudinal analysis of urinary- and erectile function after RALP in high- versus low/intermediate-risk prostate cancer in a large prospective database

A0858 - The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office

The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office

The androgen receptor depends on ligand‐binding domain dimerization for transcriptional activation

A0604 - Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

A0602 - Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

P047 - Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

Association between PSMA PET response and oncological outcome following neoadjuvant hormonal therapy in high-risk prostate cancer patients

Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

P059 - Association between PSMA PET response and oncological outcome following neoadjuvant hormonal therapy in high-risk prostate cancer patients

Be-RALP study: The effect of adjuvant treatment on quality of life, erectile function and continence

Listeria monocytogenes tijdens de zwangerschap

EAU recommendations for the diagnosis and treatment of human papillomavirus infections in men

CT texture analysis of ex vivo renal stones predicts ease of fragmentation with shock wave lithotripsy

Longitudinal QoL in patients with high versus low-intermediate risk prostate cancer treated by RALP: A multicentre study

594 - Predictive factors of postoperative quality of life, erectile function and continence after robot-assisted radical prostatectomy: A multicentre study

Predictive factors of postoperative quality of life, erectile function and continence after robot-assisted radical prostatectomy: A multicentre study

1181 - Longitudinal QoL in patients with high versus low-intermediate risk prostate cancer treated by RALP: A multicentre study

32 - CT texture analysis of ex vivo renal stones predicts ease of fragmentation with shock wave lithotripsy

CT Texture Analysis of Ex Vivo Renal Stones Predicts Ease of Fragmentation with Shockwave Lithotripsy

Suchergebnisse filtern